Bicyclo<3.2.1>octan-1-ol | 134654-98-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Bicyclo<3.2.1>octan-1-ol
• 英文别名: Bicyclo[3.2.1]octan-1-ol
• CAS: 134654-98-1
• 化学式: C₈H₁₄O
• mdl: MFCD00101893
• 分子量: 126.199
• InChiKey: YOUYXVQUIJGXKB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  Bicyclo<3.2.1>octan-1-ol 在 2-双环己基膦-2',6'-二甲氧基联苯 、 tris-(dibenzylideneacetone)dipalladium(0) 、 三氟甲磺酸 、 sodium t-butanolate 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 27.0h， 生成
  参考文献：
  名称：

  一种包含多环烷烃的芳香族衍生物及包含该 衍生物的有机电致发光器件

  摘要：

  本发明涉及一种包含多环烷烃的芳香族衍生物及包含该衍生物的有机电致发光器件，结构如下化学式Ⅰ所示：本发明化合物是包含多环烷烃为骨架的芳香族衍生物，呈现出优良的稳定性和高耐热性；能够大幅减少能量损失，能够形成稳定的稠环。本发明包含多环烷烃的芳香族衍生物能够提高有机电致发光器件中有机层的稳定性。

  公开号：

  CN110183332B
• 作为产物：
  描述：

  3-(3-Iodopropyl)cyclopentan-1-one 在 tris(dibenzoylmethano)iron(III) samarium diiodide 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 以54%的产率得到Bicyclo<3.2.1>octan-1-ol
  参考文献：
  名称：

  A facile synthesis of bicyclo[m.n.1]alkan-1-ols. Evidence for organosamarium intermediates in the samarium(II) iodide promoted intramolecular Barbier-type reaction

  摘要：

  Samarium(II) iodide (SmI2) has been successfully employed as a reductive coupling agent for the intramolecular Barbier-type synthesis of bicyclo[m.n.1]alkan-1-ols. Thus, a variety of 3-(omega-iodoalkyl)cycloalkanones, upon treatment with SmI2 and a catalytic quantity of iron complex in tetrahydrofuran (THF), provide the title compounds in excellent yields. The reaction is quite general for the construction of diverse bicyclic ring systems, including the highly strained bicyclo[2.1.1]hexan-1-ol. In addition to exploring the synthetic utility of this reaction, studies have been performed which provide insight on the mechanistic details of the SmI2-promoted intramolecular Barbier-type synthesis. Compelling evidence for the intermediacy of organosamarium species has thus been gathered.

  DOI：

  10.1021/jo00013a008

文献信息

• HETEROCYCLIC COMPOUND AND USE THEREOF
  申请人：KOIKE Tatsuki

  公开号：US20120059030A1

  公开（公告）日：2012-03-08

  The present invention provides a heterocycle derivative having a superior amyloid β production inhibitory activity and/or a superior γ-secretase modulation activity, and use thereof. A compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.

  本发明提供了一种具有优越的淀粉样蛋白β产生抑制活性和/或优越的γ-分泌酶调节活性的杂环衍生物，以及其用途。一种由下式（I）表示的化合物： 其中每个符号如本说明书中所定义，或其盐。
• METHOD FOR ASSAY ON THE EFFECT OF VASCULARIZATION INHIBITOR
  申请人：Uenaka Toshimitsu

  公开号：US20100092490A1

  公开（公告）日：2010-04-15

  The present invention provides a method of predicting the antitumor effect of an angiogenesis inhibitor. It is possible to predict the antitumor effect of an angiogenesis inhibitor by evaluating the EGF dependency of a tumor cell for proliferation and/or survival and using the EGF dependency as an indicator. Since the antitumor effect of an angiogenesis inhibitor correlates with the EGF dependency of a tumor cell for proliferation and/or survival, the angiogenesis inhibitors is capable of producing excellent antitumor effect when combined with a substance having EGF inhibitory activity.

  本发明提供了一种预测抗血管生成抑制剂的抗肿瘤效果的方法。通过评估肿瘤细胞对表皮生长因子（EGF）增殖和/或存活的依赖性，并将其作为指标，可以预测抗血管生成抑制剂的抗肿瘤效果。由于抗血管生成抑制剂的抗肿瘤效果与肿瘤细胞对EGF增殖和/或存活的依赖性相关，因此当与具有EGF抑制活性的物质结合时，抗血管生成抑制剂能够产生出色的抗肿瘤效果。
• Migration aptitudes of cyclic and polycyclic bridgehead groups in the Criegee Rearrangement
  作者：Eckehardt Wistuba、Christoph Rüchardt

  DOI：10.1016/s0040-4039(01)81913-4

  日期：1981.1

  The migration aptitudes of cyclic and polycyclic bridgehead groups in the Criegee Rearrangement support σ-neighbouring group participation by pentacoordinated bonding and vertical charge stabilisation in the migrating group and therefore favour transition state 2b and not 2a.

  Criegee重排中的环状和多环桥头基团的迁移能力通过迁移团中的五配位键合和垂直电荷稳定来支持σ邻域的参与，因此倾向于过渡态2b而不是2a。
• FUSED TRIAZOLES FOR THE TREATMENT OR PROPHYLAXIS OF MILD COGNITIVE IMPAIRMENT
  申请人：Koike Tatsuki

  公开号：US20130178497A1

  公开（公告）日：2013-07-11

  The present invention provides a heterocycle derivative having a superior amyloid β production inhibitory activity and/or a superior γ-secretase modulation activity, and use thereof. A compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.

  本发明提供了一种具有优异的淀粉样β产生抑制活性和/或优异的γ-分泌酶调节活性的杂环衍生物及其使用。化合物的公式(I)表示的化合物：其中每个符号如本说明书所定义，或其盐。
• Antibacterial solid composition for oral administation
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0163433A2

  公开（公告）日：1985-12-04

  This invention relates to an antibacterial solid composition for oral administration which comprises a lipid soluble cephalosporin compound and a cyclodextrin. The said composition provides much increased in vivo absorbability of a non-ester form of the cephalosporin compound. This composition is useful for prevention and treatment of bacterial infections.

  本发明涉及一种口服抗菌固体组合物，该组合物由脂溶性头孢菌素化合物和环糊精组成。 该组合物大大提高了头孢菌素化合物非酯形式的体内可吸收性。 该组合物可用于预防和治疗细菌感染。